H. A. Ghofrani (Giessen, Germany), O. Sitbon (Clamart, France)
Magnetic resonance to assess disease severity and response to therapy in pulmonary arterial hypertension
C. Bauleo, G. D. Aquaro, R. Pancani, B. Formichi, E. Airò, M. Perazzolo Marra, M. Lombardi, C. Marini (Via Moruzzi 1 Pisa, Via Paradisa 2 Pisa, Italy)
|  |
Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH)
J. Rakic, M. Tamm, D. Stolz (Basel, Switzerland)
| |
Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases
F. Ayala, M. D. Hernandez de Diego, S. Rosillo, T. Pulido, R. Gutierrez, E. Santos, I. Roquet, M. T. Miranda, T. Rueda, H. Peña, J. Sandoval (Mexico City, Mexico)
| |
Reduced right ventricular transverse wall motion is indicative of right ventricular dysfunction in pulmonary arterial hypertension
T. Kind, G. J. Mauritz, T. Marcus, M. van de Veerdonk, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
| |
Right ventricular function is a strong prognostic predictor of mortality in pulmonary arterial hypertension
M. van de Veerdonk, T. Kind, G. J. Mauritz, N. Westerhof, T. Marcus, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
|  |
The right ventricle (RV) in systemic sclerosis-associated pulmonary arterial hypertension (SSCPH) vs idiopathic pulmonary arterial hypertension (IPH): higher inflammatory status, no increase in interstitial fibrosis
M. Overbeek, K. Mouchaers, H. Niessen, K. Kupreishvili, A. Boonstra, J. Belien, E. Smit, A. Voskuyl, B. Dijkmans, A. Vonk-Noordegraaf, K. Grünberg (Amsterdam, Netherlands)
| |
The effect of long-term specific therapy on clinical outcome, echocardiographic and sympatho-vagal balance as assessed by heart rate variability in pulmonary arterial hypertension
M. Can, I. Tanboga, H. Tokgöz, N. Keles, F. Koca, A. Özkan, E. Türkyilmaz, O. Özveren, K. Sönmez, C. Kaymaz (Istanbul, MUS, Kütahya, Turkey)
| |
Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis
M. Ghanem, H. Makhlouf, G. Agmy (Assiut, Egypt)
| |
Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics
G. Garcia, O. Sitbon, F. Jilwan, L. Savale, D. Natali, X. Jaïs, P. Escourrou, G. Simonneau (Clamart, France)
| |
The prevalence of patent foramen ovale in chronic obstructive pulmonary disease patients with increased pulmonary hypertension
M. Nabavi Nouri, M. Rohani, S. J. Mousavi, B. Zamani, H. Yahyazadeh, H. Baradaran (Tehran, Islamic Republic Of Iran)
| |
Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial
R. S. Rao, S. Singh, B. B. Sharma, V. Singh (Jaipur, India)
| |
Detection of right-to-left shunt (RLS) in pulmonary hypertension (PH) by contrast transcranial doppler ultrasound (TCD): a pilot study
A. Crutu, A. Pavy-Le Traon, I. Frachon, Y. Jobic, C. Gut-Gobert, Y. Etienne, P. Mialon, F. Couturaud, C. Leroyer (Brest, France)
| |
An overview of drug-drug interaction studies conducted with treprostinil
K. Rollins, K. Laliberte, K. Gotzkowsky, M. Wade, R. Grover, D. Mottola (Research Triangle Park, United States Of America)
| |
Aerobic exercise capacity in COPD patients with and without pulmonary hypertension
C. Pynnaert, M. Lamotte, R. Naeije (Brussels, Belgium)
| |
Autoantibodies are frequently found in arterial and chronic thrombotic pulmonary hypertension not associated to connective tissue diseases
S. Ulrich, M. Streit, L. C. Huber, M. Fischler, R. Speich (Zurich, Switzerland)
| |
Absolute values of the 6 minute walk distance are equally good to predict disease severity in pulmonary hypertension as percent predicted formulas
S. Vatandaslar, U. Treder, M. Fischler, L. C. Huber, M. Maggiorini, R. Speich, S. Ulrich (Zurich, Switzerland)
| |
An inert-gas rebreathing device as monitoring tool in pulmonary hypertension
S. Desole, P. Heininger, C. Seemann, S. Müller, R. Hiemetzberger, C. Kähler (Innsbruck, Austria)
| |
Inert gas rebreathing: the effect of pulmonary shunt flow correction on the accuracy of cardiac output measurements in clinical practice
F. Trinkmann, T. Papavassiliu, F. Kraus, H. Leweling, S. O. Schoenberg, M. Borggrefe, J. J. Kaden, J. Saur (Mannheim, Germany)
| |
Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP
O. Hilberg, C. U. Andersen, S. Mellemkjær, J. E. Nielsen-Kudsk, B. E. Laursen, U. Simonsen (Arhus, Denmark)
| |
Pulmonary arterial pressure response during exercise in COPD patients and healthy subjects
J. Varga, I. Lajko, R. Palfoldi, A. Palinkas, A. Somfay (Deszk-Szeged, Hodmezovasarhely, Hungary)
| |